Drugmakers delay some European launches with a wary eye on Trump's pricing policies 1 / 2 [Yahoo! Finance Canada]
Insmed Incorporated (INSM)
Last insmed incorporated earnings: 4/30 07:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.insmed.com
Company Research
Source: Yahoo! Finance Canada
in Europe as the industry grapples with U.S. pressure and pricing policy shifts from President Donald Trump, according to executives, an industry trade group and data shared with Reuters. The White House has been pushing to lower ?the cost of prescription drugs in the United States, which has traditionally paid significantly more than other wealthy countries. Trump says the industry has been unfair to U.S. consumers and ?has sought to tie the cost for Americans to what is paid elsewhere, including in Europe, known as most-favoured-nation pricing. That has led drugmakers to press pause on bringing some medicines to European markets, where health spending is lower, to avoid pulling ?down prices in the $700 billion U.S. market. It has also created a complex balancing act for CEOs and Europe's healthcare policy makers. "We're seeing first signs of delayed introductions into Europe," said Stefan Oelrich, president of trade body the European Federation of Pharmaceutical Industries and
Show less
Read more
Impact Snapshot
Event Time:
INSM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
INSM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
INSM alerts
High impacting Insmed Incorporated news events
Weekly update
A roundup of the hottest topics
INSM
News
- Insmed (INSM) Is Up 10.0% After Positive ENCORE Data Position ARIKAYCE For Earlier MAC Use [Yahoo! Finance]Yahoo! Finance
- Insmed (INSM) had its price target raised by Barclays PLC from $231.00 to $237.00. They now have an "overweight" rating on the stock.MarketBeat
- Insmed (INSM) Jumps as Morgan Stanley Raises PT by 28% [Yahoo! Finance]Yahoo! Finance
- Insmed (INSM) was upgraded by Morgan Stanley from "equal weight" to "overweight". They now have a $212.00 price target on the stock.MarketBeat
- Columbia Select Large Cap Growth Fund Q4 2025 Commentary [Seeking Alpha]Seeking Alpha
INSM
Earnings
- 2/19/26 - Miss
INSM
Sec Filings
- 4/3/26 - Form 4
- 4/1/26 - Form 144
- 4/1/26 - Form ARS
- INSM's page on the SEC website